Assaying Antibodies
Drug manufacturers pinpoint techniques to analyze growing and diverse class of therapeutics
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
January 16, 2012 Cover
Volume 90, Issue 3
Drug manufacturers pinpoint techniques to analyze growing and diverse class of therapeutics
Cover image:
Credit:
Drug manufacturers pinpoint techniques to analyze growing and diverse class of therapeutics
Recent advances in instrument design and methodology provide a wealth of traditionally inaccessible data
Politically motivated public record requests for faculty messages prompt concerns over free scientific discourse
Behind every generic name lies a specific process
Fine chemicals maker Frontier Scientific confronts intellectual property theft
Patent eligibility of personalized medicine is at stake in closely watched case
Synchronized engineered bacteria sense heavy metals